Chennai Super Kings Plans To Borrow Rs 350 Crore For Future Business Plans
5 times IPL champions, CSK plans for borrowing capital of Rs 350 crore for which the company seeks various financial mediums.
An In-Depth Analysis Of Capgemini’s YoY Revenue Growth In Q1FY23
The Year-On-Year(YoY) revenue of Capgemini in Q1FY23 was $6.5 billion, which contributed 10.9% of its growth.
What Is The Revenue Model Of HDFC Securities, And How Is It Different From Its Competitors?
HDFC Securities is the best online platform for stock trading. How does the company generate revenue? Learn about its revenue model and how it differs from its peer competitors.
Hero FinCorp’s Possible Strategy For Raising Rs 4,000 Crore Via Its IPO
Hero FinCorp, a financial service arm of India’s two-wheeler giant Hero MotoCorp, announced its plans to raise a whopping amount of Rs 4,000 via its Initial Public Offering(IPO). As per the rumours in the market, the company is expected to launch its IPO in 2024. For this, Hero FinCorp also shortlisted the eight investment banks, […]
Decoding The Nse Pre-IPO Shares Price History Over The Last Five Years
NSE, India’s biggest stock exchange, has witnessed major changes in its share price in the past five years. Read this blog to know.
Why Does The NSE’s IPO Create A Buzz In The Market And Become A Preferred Choice For Investment?
The National Stock Exchange(NSE) IPO has excited retail investors in the unlisted share market. It is predicted that NSE will roll out its IPO at a market valuation of Rs. 2 lakh crore valuation.
Swiggy Vs. Zomato- A Comparison Of Business Models, Financial Performance, And More
Swiggy and Zomato are both online food aggregators operating in the same space but differ in business model and other aspects.
Decrypting NSE’s CAGR And Market Valuation In The Unlisted Share Market
As per the data shared by NSE on 31 March 2023, its total outstanding shares in the unlisted share market was approx 50 crore, which makes its market valuation of Rs 1,80,000 crore.
How NSE Unlisted Shares Can Be Multi-Bagger For Investors In The Long Run?
NSE earned 35% plus CAGR in revenue and net profits. Can NSE unlisted shares be multi-bagger for investors in the long run? Read this blog to know. nsn
An In-Depth Analysis Of PharmEasy’s Rs 3,500 Crore Right Issue Of (CCPS)B
PharmEasy invites its existing investors, including Sunil Kant Munjal’s office family, to raise Rs 3,500 crore via the right issue (CCPS)B
